-
until 2024 as the
European Monitoring Centre for
Drugs and Drug
Addiction (
EMCDDA), is an
agency of the
European Union headquartered in Lisbon, Portugal,...
-
According to the
European Monitoring Centre for
Drugs and Drug
Addiction (
EMCDDA) it has been
detected in 25
European countries with the
majority of drug...
-
Decision 2005/387/JHA)".
EMCDDA. July 2014.
Retrieved 8
August 2014.
European Monitoring Centre for
Drugs and Drug
Addiction (
EMCDDA) (2021). "Synthetic cannabinoids...
- web}}: CS1 maint:
archived copy as
title (link) "
EMCDDA:Drug
policy profiles, Portugal, June 2011".
Emcdda.europa.eu. 17
August 2011.
Retrieved 27 July 2014...
- Drug profiles.
European Monitoring Centre for
Drugs and Drug
Addiction (
EMCDDA). 8
January 2015.
Archived from the
original on 15
April 2016. Retrieved...
- 006. ISBN 9780199381708. LCCN 2016020729. "Polydrug use | www.
emcdda.europa.eu". www.
emcdda.europa.eu.
Harty PS,
Zabriskie HA,
Erickson JL,
Molling PE,...
- been sold as a
designer drug,
first being definitively identified by the
EMCDDA in
Sweden in 2016. It is the
bromo instead of
chloro analogue of alprazolam...
- However, the
Management Board of the
EMCDDA later decided to
ignore any NGO
involvement in the work of the
EMCDDA. In 1998 a
Manifesto for just and effective...
- €3 to €9 per tablet,
typically containing 25–65 mg of MDMA. By 2014 the
EMCDDA reported that the
range was more
usually between €5 and €10 per tablet,...
-
Centre for
Drugs and Drug
Addiction (
EMCDDA), 2006.
Annual Report 2006: The
State of the
Drugs Problem in Europe,
EMCDDA, Luxembourg.
UNODC Office for Russia...
